Mrs Crystal Bawuah, RN, DON | |
9 Benham Way, Sparta, NJ 07871-1155 | |
(908) 342-6330 | |
Not Available |
Full Name | Mrs Crystal Bawuah |
---|---|
Gender | Female |
Speciality | Home Health |
Location | 9 Benham Way, Sparta, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720791163 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Crystal Bawuah, RN, DON 9 Benham Way, Sparta, NJ 07871-1155 Ph: (908) 342-6330 | Mrs Crystal Bawuah, RN, DON 9 Benham Way, Sparta, NJ 07871-1155 Ph: (908) 342-6330 |
News Archive
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
The Virginia Commonwealth University Center on Health Disparities has been awarded a five-year grant renewal totaling $6.2 million from the National Institute of Health's Institute on Minority Health Disparities for research, research training and community outreach in the area of preterm birth.
The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.
UNICEF on Thursday launched a $1.2 billion appeal aimed at providing "life saving emergency assistance to millions of children and women in dire need," VOA News reports (Schlein, 2/4). "The appeal is part of UNICEF's Humanitarian Action Report 2010, released in Geneva ... which spotlights the desperate situation of children and women in 28 countries and territories facing deep humanitarian crises," the U.N. News Centre writes (2/4).
Johnson & Johnson is in advanced negotiations to buy Dutch biotechnology company Crucell NV for €1.75 billion ($2.29 billion), the two companies said today. Giles Somers, senior healthcare analyst at Datamonitor comments:
› Verified 7 days ago